Details of the Target

General Information of Target

Target ID LDTP13956
Target Name Putative RNA-binding protein Luc7-like 2 (LUC7L2)
Gene Name LUC7L2
Gene ID 51631
Synonyms
Putative RNA-binding protein Luc7-like 2
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MPFPFGKSHKSPADIVKNLKESMAVLEKQDISDKKAEKATEEVSKNLVAMKEILYGTNEK
EPQTEAVAQLAQELYNSGLLSTLVADLQLIDFEGKKDVAQIFNNILRRQIGTRTPTVEYI
CTQQNILFMLLKGYESPEIALNCGIMLRECIRHEPLAKIILWSEQFYDFFRYVEMSTFDI
ASDAFATFKDLLTRHKLLSAEFLEQHYDRFFSEYEKLLHSENYVTKRQSLKLLGELLLDR
HNFTIMTKYISKPENLKLMMNLLRDKSRNIQFEAFHVFKVFVANPNKTQPILDILLKNQA
KLIEFLSKFQNDRTEDEQFNDEKTYLVKQIRDLKRPAQQEA
Target Bioclass
Other
Family
Luc7 family
Subcellular location
Nucleus speckle
Function May bind to RNA via its Arg/Ser-rich domain.
Uniprot ID
Q9Y383
Ensemble ID
ENST00000263545.7
HGNC ID
HGNC:21608

Target Site Mutations in Different Cell Lines

Cell line Mutation details Probe for labeling this protein in this cell
HT115 SNV: p.R99C .
MFE319 SNV: p.R326G DBIA    Probe Info 
PF382 SNV: p.S315G DBIA    Probe Info 
SKMEL2 SNV: p.A109T .
SUPT1 SNV: p.R278T DBIA    Probe Info 

Probe(s) Labeling This Target

ABPP Probe
Click To Hide/Show 36 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
m-APA
 Probe Info  		10.35  LDD0402  [1]
A-EBA
 Probe Info  		4.28  LDD0215  [2]
TH211
 Probe Info  		Y196(20.00)  LDD0260  [3]
STPyne
 Probe Info  		K186(10.00); K229(6.11); K61(6.07)  LDD0277  [4]
BTD
 Probe Info  		C348(5.81)  LDD1699  [5]
ONAyne
 Probe Info  		K29(0.00); K122(0.00); K61(0.00)  LDD0273  [4]
HHS-482
 Probe Info  		Y196(0.67)  LDD0285  [6]
HHS-475
 Probe Info  		Y196(1.02)  LDD0264  [7]
HHS-465
 Probe Info  		Y196(10.00); Y371(10.00)  LDD2237  [8]
DBIA
 Probe Info  		C348(0.96); C43(0.95); C44(0.95)  LDD0078  [9]
4-Iodoacetamidophenylacetylene
 Probe Info  		C348(0.00); C97(0.00); C59(0.00); C43(0.00)  LDD0038  [10]
IA-alkyne
 Probe Info  		C43(0.00); C348(0.00); C59(0.00); C190(0.00)  LDD0032  [11]
IPIAA_H
 Probe Info  		C190(0.00); C59(0.00)  LDD0030  [12]
IPIAA_L
 Probe Info  		C97(0.00); C59(0.00); C190(0.00); C348(0.00)  LDD0031  [12]
Lodoacetamide azide
 Probe Info  		C348(0.00); C97(0.00); C59(0.00); C190(0.00)  LDD0037  [10]
JW-RF-010
 Probe Info  		N.A.  LDD0026  [13]
NAIA_4
 Probe Info  		N.A.  LDD2226  [14]
TFBX
 Probe Info  		N.A.  LDD0027  [13]
WYneN
 Probe Info  		N.A.  LDD0021  [15]
WYneO
 Probe Info  		N.A.  LDD0022  [15]
aHNE
 Probe Info  		N.A.  LDD0001  [15]
Compound 10
 Probe Info  		N.A.  LDD2216  [16]
Compound 11
 Probe Info  		N.A.  LDD2213  [16]
ENE
 Probe Info  		N.A.  LDD0006  [15]
IPM
 Probe Info  		C44(0.00); C348(0.00)  LDD0005  [15]
NHS
 Probe Info  		K122(0.00); K139(0.00)  LDD0010  [15]
SF
 Probe Info  		Y371(0.00); Y173(0.00)  LDD0028  [17]
VSF
 Probe Info  		N.A.  LDD0007  [15]
Phosphinate-6
 Probe Info  		C348(0.00); C44(0.00)  LDD0018  [18]
1c-yne
 Probe Info  		N.A.  LDD0228  [19]
1d-yne
 Probe Info  		N.A.  LDD0357  [19]
Acrolein
 Probe Info  		C43(0.00); C348(0.00); C59(0.00); H215(0.00)  LDD0217  [20]
Crotonaldehyde
 Probe Info  		C59(0.00); C348(0.00); C43(0.00)  LDD0219  [20]
Methacrolein
 Probe Info  		C43(0.00); C348(0.00); C59(0.00); C44(0.00)  LDD0218  [20]
W1
 Probe Info  		C43(0.00); C44(0.00); C59(0.00); C348(0.00)  LDD0236  [21]
NAIA_5
 Probe Info  		C97(0.00); C348(0.00); C36(0.00); C59(0.00)  LDD2223  [14]
PAL-AfBPP Probe
Click To Hide/Show 5 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
C187
 Probe Info  		21.71  LDD1865  [22]
C191
 Probe Info  		14.22  LDD1868  [22]
C193
 Probe Info  		7.84  LDD1869  [22]
Diazir
 Probe Info  		N.A.  LDD0011  [15]
DA-2
 Probe Info  		N.A.  LDD0071  [23]

Competitor(s) Related to This Target

Competitor ID Name Cell line Binding Site(Ratio) Interaction ID Ref
 LDCM0548  1-(4-(Benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)-2-nitroethan-1-one MDA-MB-231 C348(0.71); C43(0.30)  LDD2142  [5]
 LDCM0519  1-(6-methoxy-3,4-dihydroquinolin-1(2H)-yl)-2-nitroethan-1-one MDA-MB-231 C348(0.93); C43(0.31)  LDD2112  [5]
 LDCM0502  1-(Cyanoacetyl)piperidine MDA-MB-231 C348(0.86)  LDD2095  [5]
 LDCM0524  2-Cyano-N-(2-morpholin-4-yl-ethyl)-acetamide MDA-MB-231 C348(1.44); C36(1.12); C43(0.64)  LDD2117  [5]
 LDCM0558  2-Cyano-N-phenylacetamide MDA-MB-231 C348(1.15); C36(1.17); C44(0.93)  LDD2152  [5]
 LDCM0539  3-(4-Isopropylpiperazin-1-yl)-3-oxopropanenitrile MDA-MB-231 C348(0.56); C36(0.52)  LDD2132  [5]
 LDCM0538  4-(Cyanoacetyl)morpholine MDA-MB-231 C348(0.41)  LDD2131  [5]
 LDCM0545  Acetamide MDA-MB-231 C348(0.32); C36(0.48); C44(0.81)  LDD2138  [5]
 LDCM0520  AKOS000195272 MDA-MB-231 C36(0.77); C43(0.76)  LDD2113  [5]
 LDCM0020  ARS-1620 HCC44 C348(0.96); C43(0.95); C44(0.95)  LDD0078  [9]
 LDCM0498  BS-3668 MDA-MB-231 C348(0.39)  LDD2091  [5]
 LDCM0108  Chloroacetamide HeLa C59(0.00); C348(0.00); H215(0.00); C36(0.00)  LDD0222  [20]
 LDCM0632  CL-Sc Hep-G2 C348(0.91); C348(0.86); C348(0.61)  LDD2227  [14]
 LDCM0213  Electrophilic fragment 2 MDA-MB-231 C59(1.27); C348(1.12)  LDD1702  [5]
 LDCM0625  F8 Ramos C36(1.77); C348(1.93); C59(1.02); 1.91  LDD2187  [24]
 LDCM0572  Fragment10 Ramos C36(0.58); C348(0.93); C59(0.74)  LDD2189  [24]
 LDCM0573  Fragment11 Ramos C36(0.86); C348(0.03); 1.29  LDD2190  [24]
 LDCM0574  Fragment12 Ramos C36(0.52); C348(0.67); C59(0.54)  LDD2191  [24]
 LDCM0575  Fragment13 Ramos C36(0.81); C348(0.84); C59(0.93)  LDD2192  [24]
 LDCM0576  Fragment14 Ramos C36(0.73); C348(0.75); C59(0.54); 0.92  LDD2193  [24]
 LDCM0579  Fragment20 Ramos C36(0.37); C348(0.51); C59(0.60)  LDD2194  [24]
 LDCM0580  Fragment21 Ramos C36(0.89); C348(0.74); C59(1.01)  LDD2195  [24]
 LDCM0582  Fragment23 Ramos C36(1.28); C348(0.87); C59(1.38)  LDD2196  [24]
 LDCM0578  Fragment27 Ramos C36(0.92); C348(0.99); C59(0.83)  LDD2197  [24]
 LDCM0586  Fragment28 Ramos C36(0.56); C348(0.48); C59(0.38); 1.33  LDD2198  [24]
 LDCM0588  Fragment30 Ramos C36(0.87); C348(1.06); C59(0.64)  LDD2199  [24]
 LDCM0589  Fragment31 Ramos C36(0.75); C348(0.74); C59(0.83)  LDD2200  [24]
 LDCM0590  Fragment32 Ramos C36(0.58); C348(1.19); C59(0.49)  LDD2201  [24]
 LDCM0468  Fragment33 Ramos C36(1.01); C348(1.16); C59(0.86)  LDD2202  [24]
 LDCM0596  Fragment38 Ramos C36(0.95); C348(0.95); C59(0.84)  LDD2203  [24]
 LDCM0566  Fragment4 Ramos C36(0.74); C348(0.94); C59(0.72); 1.70  LDD2184  [24]
 LDCM0610  Fragment52 Ramos C36(0.81); C348(0.99); C59(1.08)  LDD2204  [24]
 LDCM0614  Fragment56 Ramos C36(0.94); C348(0.96); C59(0.94)  LDD2205  [24]
 LDCM0569  Fragment7 Ramos C36(0.61); C348(0.92); C59(0.49); 1.02  LDD2186  [24]
 LDCM0571  Fragment9 Ramos C36(0.43); C348(0.57); C59(0.52)  LDD2188  [24]
 LDCM0116  HHS-0101 DM93 Y196(1.02)  LDD0264  [7]
 LDCM0117  HHS-0201 DM93 Y196(0.78)  LDD0265  [7]
 LDCM0118  HHS-0301 DM93 Y196(0.81)  LDD0266  [7]
 LDCM0119  HHS-0401 DM93 Y196(0.86)  LDD0267  [7]
 LDCM0120  HHS-0701 DM93 Y196(1.01)  LDD0268  [7]
 LDCM0107  IAA HeLa C43(0.00); H215(0.00); H39(0.00); C44(0.00)  LDD0221  [20]
 LDCM0123  JWB131 DM93 Y196(0.67)  LDD0285  [6]
 LDCM0124  JWB142 DM93 Y196(0.56)  LDD0286  [6]
 LDCM0125  JWB146 DM93 Y196(0.93)  LDD0287  [6]
 LDCM0126  JWB150 DM93 Y196(2.77)  LDD0288  [6]
 LDCM0127  JWB152 DM93 Y196(1.56)  LDD0289  [6]
 LDCM0128  JWB198 DM93 Y196(0.97)  LDD0290  [6]
 LDCM0129  JWB202 DM93 Y196(0.57)  LDD0291  [6]
 LDCM0130  JWB211 DM93 Y196(1.01)  LDD0292  [6]
 LDCM0022  KB02 Ramos C36(0.36); C348(1.86); C59(0.52); 0.41  LDD2182  [24]
 LDCM0023  KB03 MDA-MB-231 C59(0.97)  LDD1701  [5]
 LDCM0024  KB05 COLO792 C59(1.11)  LDD3310  [25]
 LDCM0509  N-(4-bromo-3,5-dimethylphenyl)-2-nitroacetamide MDA-MB-231 C348(0.91)  LDD2102  [5]
 LDCM0528  N-(4-bromophenyl)-2-cyano-N-phenylacetamide MDA-MB-231 C348(0.41)  LDD2121  [5]
 LDCM0109  NEM HeLa H215(0.00); H63(0.00); C44(0.00)  LDD0223  [20]
 LDCM0497  Nucleophilic fragment 11b MDA-MB-231 C348(1.08)  LDD2090  [5]
 LDCM0499  Nucleophilic fragment 12b MDA-MB-231 C348(0.73)  LDD2092  [5]
 LDCM0500  Nucleophilic fragment 13a MDA-MB-231 C36(0.98); C43(1.03)  LDD2093  [5]
 LDCM0501  Nucleophilic fragment 13b MDA-MB-231 C348(1.16)  LDD2094  [5]
 LDCM0503  Nucleophilic fragment 14b MDA-MB-231 C348(0.59)  LDD2096  [5]
 LDCM0504  Nucleophilic fragment 15a MDA-MB-231 C36(0.87); C43(0.99)  LDD2097  [5]
 LDCM0505  Nucleophilic fragment 15b MDA-MB-231 C348(0.75); C43(0.47)  LDD2098  [5]
 LDCM0506  Nucleophilic fragment 16a MDA-MB-231 C348(0.86); C36(1.01); C43(0.68); C59(1.73)  LDD2099  [5]
 LDCM0507  Nucleophilic fragment 16b MDA-MB-231 C348(0.87)  LDD2100  [5]
 LDCM0508  Nucleophilic fragment 17a MDA-MB-231 C36(1.10)  LDD2101  [5]
 LDCM0511  Nucleophilic fragment 18b MDA-MB-231 C348(1.03); C43(0.25)  LDD2104  [5]
 LDCM0512  Nucleophilic fragment 19a MDA-MB-231 C348(1.15)  LDD2105  [5]
 LDCM0513  Nucleophilic fragment 19b MDA-MB-231 C348(0.83)  LDD2106  [5]
 LDCM0514  Nucleophilic fragment 20a MDA-MB-231 C348(1.25); C43(0.81); C44(0.61); C59(1.01)  LDD2107  [5]
 LDCM0515  Nucleophilic fragment 20b MDA-MB-231 C348(0.94)  LDD2108  [5]
 LDCM0516  Nucleophilic fragment 21a MDA-MB-231 C348(1.55); C36(0.61); C43(0.50); C59(1.08)  LDD2109  [5]
 LDCM0517  Nucleophilic fragment 21b MDA-MB-231 C348(2.08)  LDD2110  [5]
 LDCM0518  Nucleophilic fragment 22a MDA-MB-231 C36(0.87); C43(0.92)  LDD2111  [5]
 LDCM0521  Nucleophilic fragment 23b MDA-MB-231 C348(0.80); C43(0.75)  LDD2114  [5]
 LDCM0522  Nucleophilic fragment 24a MDA-MB-231 C36(0.57); C59(0.45)  LDD2115  [5]
 LDCM0523  Nucleophilic fragment 24b MDA-MB-231 C348(0.59)  LDD2116  [5]
 LDCM0525  Nucleophilic fragment 25b MDA-MB-231 C348(0.56)  LDD2118  [5]
 LDCM0526  Nucleophilic fragment 26a MDA-MB-231 C36(1.87); C43(1.89); C59(1.84)  LDD2119  [5]
 LDCM0527  Nucleophilic fragment 26b MDA-MB-231 C348(0.88)  LDD2120  [5]
 LDCM0529  Nucleophilic fragment 27b MDA-MB-231 C348(0.49)  LDD2122  [5]
 LDCM0530  Nucleophilic fragment 28a MDA-MB-231 C348(0.99); C36(0.85); C43(0.35); C59(0.87)  LDD2123  [5]
 LDCM0531  Nucleophilic fragment 28b MDA-MB-231 C348(0.50)  LDD2124  [5]
 LDCM0532  Nucleophilic fragment 29a MDA-MB-231 C348(1.14); C36(0.84); C43(0.82); C59(1.28)  LDD2125  [5]
 LDCM0533  Nucleophilic fragment 29b MDA-MB-231 C348(0.60)  LDD2126  [5]
 LDCM0534  Nucleophilic fragment 30a MDA-MB-231 C348(1.18); C36(1.26); C43(0.74)  LDD2127  [5]
 LDCM0535  Nucleophilic fragment 30b MDA-MB-231 C348(1.08)  LDD2128  [5]
 LDCM0536  Nucleophilic fragment 31 MDA-MB-231 C348(0.45); C36(1.21); C43(1.09)  LDD2129  [5]
 LDCM0540  Nucleophilic fragment 35 MDA-MB-231 C36(0.67); C43(0.63)  LDD2133  [5]
 LDCM0541  Nucleophilic fragment 36 MDA-MB-231 C36(0.68); C43(0.58); C59(0.40)  LDD2134  [5]
 LDCM0542  Nucleophilic fragment 37 MDA-MB-231 C348(0.64); C36(1.26); C43(0.98)  LDD2135  [5]
 LDCM0543  Nucleophilic fragment 38 MDA-MB-231 C348(1.01); C36(1.05); C43(1.10); C44(0.98)  LDD2136  [5]
 LDCM0544  Nucleophilic fragment 39 MDA-MB-231 C36(1.03); C43(0.75); C44(0.61); C59(1.32)  LDD2137  [5]
 LDCM0211  Nucleophilic fragment 3b MDA-MB-231 C36(1.38)  LDD1700  [5]
 LDCM0546  Nucleophilic fragment 40 MDA-MB-231 C348(0.95); C36(0.70); C43(0.84); C59(0.89)  LDD2140  [5]
 LDCM0549  Nucleophilic fragment 43 MDA-MB-231 C348(1.18); C44(0.63)  LDD2143  [5]
 LDCM0550  Nucleophilic fragment 5a MDA-MB-231 C36(2.84); C43(1.38); C44(1.75); C59(2.49)  LDD2144  [5]
 LDCM0552  Nucleophilic fragment 6a MDA-MB-231 C348(0.66); C36(0.91); C43(0.92)  LDD2146  [5]
 LDCM0553  Nucleophilic fragment 6b MDA-MB-231 C348(4.08); C43(0.77); C193(1.68)  LDD2147  [5]
 LDCM0554  Nucleophilic fragment 7a MDA-MB-231 C36(0.59); C43(0.46); C59(0.57)  LDD2148  [5]
 LDCM0555  Nucleophilic fragment 7b MDA-MB-231 C348(0.66)  LDD2149  [5]
 LDCM0556  Nucleophilic fragment 8a MDA-MB-231 C348(0.43); C36(0.56)  LDD2150  [5]
 LDCM0557  Nucleophilic fragment 8b MDA-MB-231 C348(1.02)  LDD2151  [5]
 LDCM0559  Nucleophilic fragment 9b MDA-MB-231 C348(1.01)  LDD2153  [5]
 LDCM0627  NUDT7-COV-1 HEK-293T C348(2.53); C59(1.09)  LDD2206  [26]
 LDCM0628  OTUB2-COV-1 HEK-293T C44(0.81); C348(0.61)  LDD2207  [26]
 LDCM0131  RA190 MM1.R C348(1.12)  LDD0304  [27]

The Interaction Atlas With This Target

The Protein(s) Related To This Target

Enzyme
Click To Hide/Show 2 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
SRSF protein kinase 1 (SRPK1) CMGC Ser/Thr protein kinase family Q96SB4
SRSF protein kinase 2 (SRPK2) CMGC Ser/Thr protein kinase family P78362
Transporter and channel
Click To Hide/Show 2 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Cilium assembly protein DZIP1 (DZIP1) DZIP C2H2-type zinc-finger protein family Q86YF9
Huntingtin (HTT) Huntingtin family P42858
Transcription factor
Click To Hide/Show 1 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Nuclear transcription factor Y subunit alpha (NFYA) NFYA/HAP2 subunit family P23511
Other
Click To Hide/Show 6 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Microtubule-associated proteins 1A/1B light chain 3B (MAP1LC3B) ATG8 family Q9GZQ8
Serine/arginine repetitive matrix protein 4 (SRRM4) NSR100 family A7MD48
Serine/arginine-rich splicing factor 6 (SRSF6) Splicing factor SR family Q13247
Serine/arginine-rich splicing factor 7 (SRSF7) Splicing factor SR family Q16629
Amyloid protein-binding protein 2 (APPBP2) . Q92624
U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 (ZRSR2) . Q15696

References

1 Quantitative and Site-Specific Chemoproteomic Profiling of Targets of Acrolein. Chem Res Toxicol. 2019 Mar 18;32(3):467-473. doi: 10.1021/acs.chemrestox.8b00343. Epub 2019 Jan 15.
2 2-Ethynylbenzaldehyde-Based, Lysine-Targeting Irreversible Covalent Inhibitors for Protein Kinases and Nonkinases. J Am Chem Soc. 2023 Feb 12. doi: 10.1021/jacs.2c11595. Online ahead of print.
Mass spectrometry data entry: PXD037665
3 Chemoproteomic profiling of kinases in live cells using electrophilic sulfonyl triazole probes. Chem Sci. 2021 Jan 21;12(9):3295-3307. doi: 10.1039/d0sc06623k.
4 A Paal-Knorr agent for chemoproteomic profiling of targets of isoketals in cells. Chem Sci. 2021 Oct 15;12(43):14557-14563. doi: 10.1039/d1sc02230j. eCollection 2021 Nov 10.
Mass spectrometry data entry: PXD028270
5 Nucleophilic covalent ligand discovery for the cysteine redoxome. Nat Chem Biol. 2023 Nov;19(11):1309-1319. doi: 10.1038/s41589-023-01330-5. Epub 2023 May 29.
Mass spectrometry data entry: PXD039908 , PXD029761
6 Chemoproteomic profiling of kinases in live cells using electrophilic sulfonyl triazole probes. Chem Sci. 2021 Jan 21;12(9):3295-3307. doi: 10.1039/d0sc06623k.
7 Discovery of a Cell-Active SuTEx Ligand of Prostaglandin Reductase 2. Chembiochem. 2021 Jun 15;22(12):2134-2139. doi: 10.1002/cbic.202000879. Epub 2021 Apr 29.
8 Global targeting of functional tyrosines using sulfur-triazole exchange chemistry. Nat Chem Biol. 2020 Feb;16(2):150-159. doi: 10.1038/s41589-019-0404-5. Epub 2019 Nov 25.
9 Reimagining high-throughput profiling of reactive cysteines for cell-based screening of large electrophile libraries. Nat Biotechnol. 2021 May;39(5):630-641. doi: 10.1038/s41587-020-00778-3. Epub 2021 Jan 4.
10 Enhancing Cysteine Chemoproteomic Coverage through Systematic Assessment of Click Chemistry Product Fragmentation. Anal Chem. 2022 Mar 8;94(9):3800-3810. doi: 10.1021/acs.analchem.1c04402. Epub 2022 Feb 23.
Mass spectrometry data entry: PXD028853
11 SP3-FAIMS Chemoproteomics for High-Coverage Profiling of the Human Cysteinome*. Chembiochem. 2021 May 14;22(10):1841-1851. doi: 10.1002/cbic.202000870. Epub 2021 Feb 18.
Mass spectrometry data entry: PXD023056 , PXD023059 , PXD023058 , PXD023057 , PXD023060
12 SP3-Enabled Rapid and High Coverage Chemoproteomic Identification of Cell-State-Dependent Redox-Sensitive Cysteines. Mol Cell Proteomics. 2022 Apr;21(4):100218. doi: 10.1016/j.mcpro.2022.100218. Epub 2022 Feb 25.
Mass spectrometry data entry: PXD029500 , PXD031647
13 Chemoproteomic Profiling by Cysteine Fluoroalkylation Reveals Myrocin G as an Inhibitor of the Nonhomologous End Joining DNA Repair Pathway. J Am Chem Soc. 2021 Dec 8;143(48):20332-20342. doi: 10.1021/jacs.1c09724. Epub 2021 Nov 24.
Mass spectrometry data entry: PXD029255
14 N-Acryloylindole-alkyne (NAIA) enables imaging and profiling new ligandable cysteines and oxidized thiols by chemoproteomics. Nat Commun. 2023 Jun 15;14(1):3564. doi: 10.1038/s41467-023-39268-w.
Mass spectrometry data entry: PXD041264
15 A modification-centric assessment tool for the performance of chemoproteomic probes. Nat Chem Biol. 2022 Aug;18(8):904-912. doi: 10.1038/s41589-022-01074-8. Epub 2022 Jul 21.
Mass spectrometry data entry: PXD027758 , PXD027755 , PXD027760 , PXD027762 , PXD027756 , PXD027591 , PXD007149 , PXD030064 , PXD032392 , PXD027789 , PXD027767 , PXD027764
16 Multiplexed CuAAC Suzuki-Miyaura Labeling for Tandem Activity-Based Chemoproteomic Profiling. Anal Chem. 2021 Feb 2;93(4):2610-2618. doi: 10.1021/acs.analchem.0c04726. Epub 2021 Jan 20.
Mass spectrometry data entry: PXD022279
17 Solid Phase Synthesis of Fluorosulfate Containing Macrocycles for Chemoproteomic Workflows. bioRxiv [Preprint]. 2023 Feb 18:2023.02.17.529022. doi: 10.1101/2023.02.17.529022.
Mass spectrometry data entry: PXD039931
18 DFT-Guided Discovery of Ethynyl-Triazolyl-Phosphinates as Modular Electrophiles for Chemoselective Cysteine Bioconjugation and Profiling. Angew Chem Int Ed Engl. 2022 Oct 10;61(41):e202205348. doi: 10.1002/anie.202205348. Epub 2022 Aug 22.
Mass spectrometry data entry: PXD033004
19 Tunable Amine-Reactive Electrophiles for Selective Profiling of Lysine. Angew Chem Int Ed Engl. 2022 Jan 26;61(5):e202112107. doi: 10.1002/anie.202112107. Epub 2021 Dec 16.
20 ACR-Based Probe for the Quantitative Profiling of Histidine Reactivity in the Human Proteome. J Am Chem Soc. 2023 Mar 8;145(9):5252-5260. doi: 10.1021/jacs.2c12653. Epub 2023 Feb 27.
21 Oxidant-Induced Bioconjugation for Protein Labeling in Live Cells. ACS Chem Biol. 2023 Jan 20;18(1):112-122. doi: 10.1021/acschembio.2c00740. Epub 2022 Dec 21.
22 Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cells. Science. 2024 Apr 26;384(6694):eadk5864. doi: 10.1126/science.adk5864. Epub 2024 Apr 26.
Mass spectrometry data entry: PXD041587
23 Cell-based proteome profiling of potential dasatinib targets by use of affinity-based probes. J Am Chem Soc. 2012 Feb 15;134(6):3001-14. doi: 10.1021/ja208518u. Epub 2012 Feb 1.
24 Site-specific quantitative cysteine profiling with data-independent acquisition-based mass spectrometry. Methods Enzymol. 2023;679:295-322. doi: 10.1016/bs.mie.2022.07.037. Epub 2022 Sep 7.
Mass spectrometry data entry: PXD027578
25 DrugMap: A quantitative pan-cancer analysis of cysteine ligandability. Cell. 2024 May 9;187(10):2536-2556.e30. doi: 10.1016/j.cell.2024.03.027. Epub 2024 Apr 22.
Mass spectrometry data entry: PXD047840
26 Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening. J Am Chem Soc. 2019 Jun 5;141(22):8951-8968. doi: 10.1021/jacs.9b02822. Epub 2019 May 22.
27 Physical and Functional Analysis of the Putative Rpn13 Inhibitor RA190. Cell Chem Biol. 2020 Nov 19;27(11):1371-1382.e6. doi: 10.1016/j.chembiol.2020.08.007. Epub 2020 Aug 27.